secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-09-24T21:36:19+00:00
Accession:  0001193125-26-401239
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 1.02, 3.02, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Jaguar Health exchanges $6.73M Streeterville debt for 729,989 shares at ~$9.22; 2025 Note fully cancelled
--------------------------------------------------------------------------------

- 2021 Note exchange: issued 182,091 shares to Streeterville for a $1,678,320 reduction of the secured note originally issued Jan. 19, 2021 with a $6,220,812.50 principal.
- 2025 Note exchange: issued 547,898 shares for a $5,049,909.26 reduction, fully paying off and cancelling the $10,810,000 note issued Nov. 12, 2025.
- Implied exchange price of roughly $9.22/share on 729,989 total new shares, versus ~1,463,958 shares outstanding as of Sept. 24, 2026 — about 50% dilution.
- Shares delivered via DWAC free of restrictive legends, issued under the Section 3(a)(9) exemption; Streeterville capped at 9.99% beneficial ownership.
- Original 2021 Note remains in force for its remaining balance; Streeterville is the noteholder and counterparty, Lisa A. Conte signed as Jaguar CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526401239/0001193125-26-401239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526401239/d130901d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-401239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer